High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer

[1]  Howard H. Yang,et al.  The genomic landscape of metastasis in treatment-naïve breast cancer models , 2019, bioRxiv.

[2]  David L. Marron,et al.  Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer , 2018, The Journal of clinical investigation.

[3]  J. Gustafsson,et al.  Intratumor heterogeneity predicts metastasis of triple-negative breast cancer , 2017, Carcinogenesis.

[4]  P. Lønning,et al.  Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.

[5]  L. Bystrykh,et al.  Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding. , 2017, Blood.

[6]  Lajos Pusztai,et al.  Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations , 2017, Nature Communications.

[7]  Carlos Caldas,et al.  Intersect-then-combine approach: improving the performance of somatic variant calling in whole exome sequencing data using multiple aligners and callers , 2017, Genome Medicine.

[8]  Jeffrey T. Chang,et al.  Planning bioinformatics workflows using an expert system , 2017, Bioinform..

[9]  Christopher A. Miller,et al.  Correction: Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases , 2017, PLoS medicine.

[10]  François Vaillant,et al.  Patient-derived xenograft (PDX) models in basic and translational breast cancer research , 2016, Cancer and Metastasis Reviews.

[11]  Stephen Fox,et al.  The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program “CASCADE” , 2016, PLoS medicine.

[12]  Christopher A. Miller,et al.  Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases , 2016, PLoS medicine.

[13]  V. Seshan,et al.  FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing , 2016, Nucleic acids research.

[14]  A. Filby,et al.  Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia , 2016, Leukemia.

[15]  Ali Bashashati,et al.  Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer , 2016, Nature Genetics.

[16]  Nipun A. Mistry,et al.  p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer , 2016, Breast Cancer Research.

[17]  G. Getz,et al.  Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition , 2016, Nature Medicine.

[18]  A. Harris,et al.  Blood vessels and cancer much more than just angiogenesis , 2015, Cell Death Discovery.

[19]  Robert T. Jones,et al.  Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. , 2015, Cancer discovery.

[20]  Andrew Menzies,et al.  Subclonal diversification of primary breast cancer revealed by multiregion sequencing , 2015, Nature Medicine.

[21]  Joshua M. Korn,et al.  Studying clonal dynamics in response to cancer therapy using high-complexity barcoding , 2015, Nature Medicine.

[22]  Steffen Dickopf,et al.  A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis , 2015, Nature.

[23]  C. D. Savci-Heijink,et al.  Retrospective analysis of metastatic behaviour of breast cancer subtypes , 2015, Breast Cancer Research and Treatment.

[24]  M. Nykter,et al.  The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.

[25]  Evis Sala,et al.  Spatial and Temporal Heterogeneity in High-Grade Serous Ovarian Cancer: A Phylogenetic Analysis , 2015, PLoS medicine.

[26]  Martin Hirst,et al.  DNA barcoding reveals diverse growth kinetics of human breast tumour subclones in serially passaged xenografts , 2014, Nature Communications.

[27]  L. Bystrykh,et al.  Tracing Dynamics and Clonal Heterogeneity of Cbx7-Induced Leukemic Stem Cells by Cellular Barcoding , 2014, Stem cell reports.

[28]  Sohrab P. Shah,et al.  Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution , 2014, Nature.

[29]  Li Ding,et al.  Clonal Architectures and Driver Mutations in Metastatic Melanomas , 2014, PloS one.

[30]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[31]  Shibing Deng,et al.  Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing. , 2014, Genomics.

[32]  K. Polyak,et al.  Non-cell autonomous tumor-growth driving supports sub-clonal heterogeneity , 2014, Nature.

[33]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[34]  Funda Meric-Bernstam,et al.  Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer , 2014, Molecular Cancer Therapeutics.

[35]  M. J. van de Vijver,et al.  Genomic evolution from primary breast carcinoma to distant metastasis: Few copy number changes of breast cancer related genes. , 2014, Cancer letters.

[36]  M. Hirst,et al.  Clonal analysis via barcoding reveals diverse growth and differentiation of transplanted mouse and human mammary stem cells. , 2014, Cell stem cell.

[37]  K. Robasky,et al.  The role of replicates for error mitigation in next-generation sequencing , 2013, Nature Reviews Genetics.

[38]  Georgina L Ryland,et al.  A simple consensus approach improves somatic mutation prediction accuracy , 2013, Genome Medicine.

[39]  Li Ding,et al.  Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. , 2013, Cell reports.

[40]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[41]  A. Chenchik,et al.  Measurement of Cancer Cell Growth Heterogeneity through Lentiviral Barcoding Identifies Clonal Dominance as a Characteristic of In Vivo Tumor Engraftment , 2013, PloS one.

[42]  K. Pogoda,et al.  Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients , 2013, Medical Oncology.

[43]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[44]  M. Ellis,et al.  Erratum: Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (Journal of Clinical Investigation (2012) 122, 4 (1541-1552) DOI: 10.1172/JCI58765) , 2012 .

[45]  Fei Li,et al.  Consensus Rules in Variant Detection from Next-Generation Sequencing Data , 2012, PloS one.

[46]  A. Børresen-Dale,et al.  The Life History of 21 Breast Cancers , 2012, Cell.

[47]  Irmtraud M. Meyer,et al.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.

[48]  M. Ellis,et al.  Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. , 2012, The Journal of clinical investigation.

[49]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[50]  P. Friedl,et al.  Extracellular matrix determinants of proteolytic and non-proteolytic cell migration. , 2011, Trends in cell biology.

[51]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[52]  D. Shibata.  Mutation and epigenetic molecular clocks in cancer. , 2011, Carcinogenesis.

[53]  Jorge S Reis-Filho,et al.  Triple-negative breast cancer. , 2010, The New England journal of medicine.

[54]  M. Nowak,et al.  Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer , 2010, Nature.

[55]  Andrew Menzies,et al.  The patterns and dynamics of genomic instability in metastatic pancreatic cancer , 2010, Nature.

[56]  Joshua F. McMichael,et al.  Genome Remodeling in a Basal-like Breast Cancer Metastasis and Xenograft , 2010, Nature.

[57]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[58]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[59]  Jun Luo,et al.  Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.

[60]  Päivi Heikkilä,et al.  Evaluation of RAD50 in familial breast cancer predisposition , 2006, International journal of cancer.

[61]  T. Ludwig.  Local proteolytic activity in tumor cell invasion and metastasis. , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[62]  David Piwnica-Worms,et al.  Real-time imaging of ligand-induced IKK activation in intact cells and in living mice , 2005, Nature Methods.

[63]  R. Weinberg,et al.  Reconstruction of functionally normal and malignant human breast tissues in mice. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[64]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[65]  I. Fidler,et al.  Seed and soil revisited: contribution of the organ microenvironment to cancer metastasis. , 2001, Surgical oncology clinics of North America.

[66]  Alexander van Oudenaarden,et al.  Genetic and phenotypic diversity in breast tumor metastases. , 2014, Cancer research.

[67]  S. C. Chen,et al.  Distant metastasis in triple-negative breast cancer. , 2013, Neoplasma.

[68]  V. Kaul,et al.  Planning , 2012 .

[69]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[70]  F. Brinkman,et al.  Phylogenetic analysis. , 1998, Methods of biochemical analysis.